Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Healthy Male and Female Volunteers

NCT00665665 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00665665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00665665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Healthy Male and Female Volunteers
Lead sponsor
Novo Nordisk A/S
Phase
Phase 1
Overall status
Terminated
Start date
November 30, 2007
Completion date
October 31, 2008
Enrollment
101 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metabolism and nutrition disorder, obesity